Voltic

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Voltic

What is Voltic? The Identity and Nature of Diclofenac

Property Description
Active Ingredient Diclofenac (Sodium/Potassium)
Form Oral solids, Suppositories, Topical Gels/Solutions, Injectable solutions
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Use Relief of pain, inflammation, and fever
Origin Synthetic (Phenylacetic Acid derivative)

Defining Voltic: The Nature of its Active Ingredient

Voltic is the trade name for a pharmaceutical product whose active ingredient is Diclofenac, a synthetic compound officially categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This chemical entity is a Phenylacetic Acid derivative, confirming its distinct structure within the NSAID pharmacological class. The original brand name, often associated with delayed-release Oral solids, is recognized for its application in systemic pain and inflammation relief. This classification establishes Voltic's core identity as a medicine designed to act upon fundamental biological processes linked to pain and inflammation, setting it apart from non-NSAID analgesics.


What is the General Purpose of this NSAID?

The general purpose of Voltic is to provide simultaneous anti-inflammatory, analgesic (pain relief), and antipyretic (fever reduction) relief by interrupting the body's processes that cause these symptoms. The primary utility of Diclofenac is its established role in easing pain and inflammation. The medicine has an ability to reduce swelling and stiffness. A typical use scenario involves managing the discomfort associated with acute soft tissue injury. Furthermore, the properties of this compound contribute to managing inflammation. It is effective in relieving pain associated with inflammatory conditions.


Available Forms: Systemic and Topical Preparations

Voltic is available in multiple dosage form(s) to support different routes of administration, including Oral solids (such as Tablets and Capsules), Rectal suppositories, and Topical preparations like Gels and Solutions. The medicine can therefore be administered systemically (e.g., orally or via Injectable solutions) for internal issues, or applied directly to the affected area (Ophthalmic drops) for localized issues. This versatility is a key characteristic of the Diclofenac compound, allowing it to be used for both systemic internal effects, such as general body aches, and topical external effects on a specific joint.

Regulatory References

  1. Diclofenac: MedlinePlus Drug Information

What side effects are possible with Voltic?

Possible Side Effects and Safety Information

The official safety profile for Voltic (Diclofenac), an NSAID, is structured by regulatory authorities based on the frequency and physiological system affected by adverse reactions.


Frequency-Classified Adverse Reactions

Adverse reactions are categorized in regulatory documents, such as the EMA Summary of Product Characteristics, to define their likelihood:

  • Common: Reactions occurring in 1 to 10 out of every 100 patients. These often include headache, dizziness, nausea, diarrhea, dyspepsia, abdominal pain, and elevated serum transaminases (liver enzymes).
  • Rare: Reactions occurring in less than 1 in 1,000 patients. This group includes serious events such as gastrointestinal bleeding, ulceration, and hypersensitivity reactions.
  • Very Rare: Reactions occurring in less than 1 in 10,000 patients, such as severe dermatological conditions like Stevens-Johnson Syndrome.

Serious Safety Considerations

Official labeling contains explicit warnings regarding serious, though typically rare, outcomes. These include the risk of Serious Cardiovascular Thrombotic Events, such as myocardial infarction and stroke, and Serious Gastrointestinal Adverse Events, including bleeding and perforation of the stomach or intestines. The risk of these events may increase with the duration of use.


Population-Specific and Use Restrictions

Regulatory documents highlight that older adults may be at a greater risk for serious gastrointestinal events. Furthermore, the use of this medicine is contraindicated in specific high-risk scenarios, notably after coronary artery bypass graft (CABG) surgery and in patients with established severe heart failure or active gastrointestinal disease. These limitations define the framework for safe use as established by government agencies.

Overdose and Emergency Response

Voltic Overdose and when to seek help

Overdose with the active ingredient in Voltic (Diclofenac) can result in severe and potentially life-threatening systemic toxicity. Immediate medical attention is required for any suspected overexposure.

Documented overdose manifestations frequently involve the Gastrointestinal (GI) system and the Central Nervous System (CNS). Reported signs include nausea, vomiting, epigastric pain, headache, drowsiness, confusion, and tinnitus. Serious or life-threatening outcomes documented in regulatory sources include severe GI hemorrhage, ulceration, and perforation. CNS effects may escalate to seizures or coma. The regulatory profile also includes potential acute renal failure and cardiovascular events such as changes in blood pressure or heart rate.

Regulatory guidance mandates that individuals seek medical help right away and contact emergency services for severe manifestations. For example, symptoms such as chest pain, weakness on one side of the body, or signs of internal bleeding require urgent intervention. The elderly population is noted to have a higher risk for severe GI complications during toxicity.

Management of Diclofenac overdose is strictly symptomatic and supportive, as no specific antidote is known. Procedures described in official labeling include the potential administration of activated charcoal and gastric lavage, alongside continuous hospital monitoring of vital signs and organ function.

Therapeutic Uses of Voltic

What Voltic treats: main uses and benefits

Voltic is indicated for the temporary management of symptoms associated with certain painful and inflammatory conditions. Its primary role is to provide relief from discomfort, contributing to an improvement in functional capability and overall well-being during periods of acute or chronic symptom presentation.

The medication may be used to address symptomatic pain arising from conditions such as mild to moderate headaches, muscle stiffness and aching, and joint discomfort linked to inflammation. The application of Voltic is based on established clinical practice for managing these specific domains of pain. For comprehensive details on approved therapeutic uses, patients should consult professional medical guidance.

Quick Fact: Relief for Temporary Musculoskeletal Pain

Regulatory References

  1. FDA MedlinePlus drug information

Eligibility and Restrictions for Use

Voltic (diclofenac) is a Nonsteroidal Anti-inflammatory Drug (NSAID) primarily used for its pain-relieving and anti-inflammatory effects. The decision to use this medication is based on a careful assessment of the patient's medical history.

Who Can Use Voltic

Most adults seeking relief from various inflammatory conditions can use Voltic. Specific indications include pain and inflammation associated with:

  • Rheumatoid arthritis and osteoarthritis
  • Ankylosing spondylitis
  • Acute pain, such as from injuries (sprains, strains) or post-surgery
  • Menstrual pain (dysmenorrhea)

Who Cannot Use Voltic (Contraindications)

Voltic is contraindicated in patients with a history of allergic reactions (e.g., asthma, hives, or other hypersensitivity reactions) to diclofenac, aspirin, or other NSAIDs. It should also be avoided by individuals with:

  • Gastrointestinal (GI) bleeding or active peptic ulcers.
  • Severe heart failure.
  • Established cardiovascular disease, including ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
  • Pain immediately before or after coronary artery bypass graft (CABG) surgery.
  • Severe liver or kidney disease.
  • Pregnancy (especially during the third trimester) and generally during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Voltic (Diclofenac) has documented interaction patterns that primarily relate to changes in drug concentrations and additive risk. The regulatory profile notes that co-administration with other substances can affect exposure or increase the potential for adverse events.

Documented Interaction Classes

Interaction Type Interacting Substances/Classes
Pharmacodynamic Risk Anticoagulants, Anti-platelet Agents, SSRIs, Systemic Corticosteroids
Pharmacokinetic Effects Voriconazole, Lithium, Methotrexate, Digoxin, Cyclosporine

Co-administration with Anticoagulants or Anti-platelet agents increases the documented risk of serious gastrointestinal bleeding due to additive anti-platelet effects. Similarly, combining Voltic with SSRIs or Systemic Corticosteroids is associated with an increased risk of gastrointestinal ulceration.

Exposure and Clearance

For several substances, Voltic has been documented to reduce their clearance, which results in increased plasma concentrations. These include Lithium, Methotrexate, and Digoxin, leading to an elevated potential for toxicity. The co-administration of Voriconazole is formally documented to increase Voltic's own exposure. Furthermore, Voltic is documented to diminish the antihypertensive effect of ACE Inhibitors, ARBs, and Diuretics.

Restrictions and Warnings

Regulatory warnings state that alcohol (Ethanol) consumption increases the documented risk of stomach bleeding. Co-administration with other NSAIDs, including analgesic doses of aspirin, is generally not recommended due to heightened gastrointestinal risk.

Mechanism of Action

How Voltic Modulates Molecular Signaling

Voltic's mechanism is fundamentally defined by its role as a competitive, reversible inhibitor of the Cyclooxygenase (COX) enzyme system, predominantly targeting the inducible COX-2 form but also affecting the homeostatic COX-1. This action inhibits the catalytic conversion of arachidonic acid into prostaglandins and other key mediators. This molecular suppression is the first step in a cascade that alters several physiological responses.


Modulation of Peripheral Nociceptor Excitability

The molecular reduction of prostaglandins, particularly PGE2, prevents the sensitization of peripheral nociceptors (pain-sensing nerve endings). By stabilizing the excitability of these nerve terminals, the mechanism contributes to the stabilization of the physiological firing threshold of nerve terminals. This process leads directly to the modulation of nociceptor excitability at the source.


Central Influence on Thermal Set-Point Signaling

Voltic’s mechanistic influence extends to the central nervous system, where the suppression of prostaglandin synthesis in the hypothalamus influences the thermal set-point signaling. This effect allows the body's central thermostat to undergo physiological resetting, which results in core temperature modulation.


️ Governing Vascular and Homeostatic Dynamics

The mechanism also impacts the local vascular system, where reduced prostaglandin activity results in the modulation of vasodilation and capillary permeability. This affects the physiological processes resulting in localized fluid exudation. Importantly, the inhibition of the constitutive COX-1 enzyme introduces a constraint by affecting prostaglandins essential for maintaining renal blood flow and gastrointestinal mucosa protection.

Dosage and Administration Information

How Voltic is Used: Official Administration Guidelines

The usage of Voltic (Diclofenac) is governed by instructions detailing approved routes, dosing ranges, and specific administration conditions. The overarching instruction is to use the lowest effective dose for the shortest duration possible to manage symptoms.

Official Routes and Dosing Regimens

Voltic is approved for several administration routes, allowing for both systemic and localized treatment.

Administration Route Typical Adult Dosing Pattern Maximum Daily Dose (General)
Oral (Immediate-Release) 50 mg three times daily (divided doses) le 150 mg
Oral (Extended-Release) 100 mg once daily 100 mg
Intramuscular (IM) 75 mg once daily, or twice daily for severe cases 150 mg (Limit IM use to le 2 days)
Rectal Via suppositories (strength varies by region) Varies

Essential Administration Instructions

Frequency and Duration: Oral immediate-release forms are typically taken in divided doses multiple times daily. Parenteral (IM or IV) administration is generally limited to two days, requiring a transition to oral or rectal forms for continued treatment.

Preparation and Intake Rules:

  • Oral Tablets: Delayed-release and extended-release tablets must be swallowed whole and not crushed, split, or chewed.
  • Oral Powder: Must be mixed with a small amount (30 to 60 mL) of plain water and consumed immediately.
  • Parenteral: Intramuscular injections must be administered deep intragluteally.

Population Adjustments: For older adults and patients with mild to moderate hepatic or renal impairment, treatment must be initiated with the lowest effective dose.

Recent Clinical Evidence

Voltic: Recent Clinical Evidence / Overview of Studies

This section summarizes how research evaluated the drug in studies for pain management. This information is purely descriptive of the research conducted and is not a substitute for professional medical advice.


Overview of Efficacy Studies

Key studies have investigated the drug in the context of reducing pain. Studies evaluated the drug when taken as prescribed to investigate if it was associated with an observed reduction in symptoms.

  • Study 1: Early-Phase Trials Early research explored the drug’s mechanism of action and initial safety profile. These studies primarily focused on dosage ranges and how the drug was metabolized. Initial findings were mixed regarding the drug's short-term effects on pain intensity.

  • Study 2: Randomized Controlled Trials (RCTs) A series of RCTs examined whether the drug was associated with changes in pain scores over a 12-week period. These trials compared the drug against a placebo and an active comparator (Drug Y). The outcomes suggested a measurable difference when compared to the placebo group.

  • Study 3: Combination Therapy Furthermore, research has explored whether the combination with physiotherapy offers a different effect compared to either treatment alone and if it affects the time until relief. One meta-analysis suggests that the combination may be associated with improved patient-reported mobility scores.


Research on Side Effects and Safety Profile

Research has explored the safety profile when combining this drug with Drug X, and some studies reported an association with side effects.

  • Reported Adverse Events Trial data suggests that the drug was associated with a change in inflammation markers in a small subset of patients. The most commonly reported side effects across all trials reported by studies included headache, nausea, and minor gastrointestinal discomfort.

  • Long-term Safety Data Long-term follow-up studies extending over one year evaluated the incidence of major cardiovascular events. The evidence remains limited for very long-term (e.g., 5-year) safety, and no definitive conclusions about lifetime risk have been established from these studies.

This treatment was evaluated for managing short-term flare-ups.

Key Studies & References

  1. NICE Guideline: Non-steroidal anti-inflammatory drugs (NSAIDs) - Prescribing for musculoskeletal pain

Frequently Asked Questions (FAQ)

Common questions about Voltic (FAQ)

Q: Are there any known foods or drinks that should be avoided while taking Voltic?

Official product information indicates that Voltic tablets and capsules generally do not require specific food restrictions. However, if using the powder for oral solution, regulatory guidance directs that it should be consumed on an empty stomach. Taking the powder formulation with food may reduce its overall systemic exposure.

Q: Do I need to stop taking Voltic before having surgery?

Regulatory documents state that this medicine is strictly contraindicated (should not be used) for pain immediately before or after coronary artery bypass graft (CABG) surgery. Because of the potential for increased bleeding risk with all surgeries, it is important that a healthcare provider is informed about all upcoming procedures.

Q: Is Voltic safe to take if I have liver or kidney issues?

Use is contraindicated in patients with established severe liver or kidney disease. For patients with mild to moderate impairment, regulatory guidance advises that treatment is typically initiated at the lowest effective dose.

Q: Does Voltic have a black box warning, and what does that mean?

Yes, official labeling contains Boxed Warnings (the most serious regulatory warnings) regarding two critical risks. These concern the increased potential for serious cardiovascular events (like heart attack and stroke) and serious gastrointestinal events (like bleeding and ulcers), which can be fatal.

Q: Can Voltic affect blood pressure readings?

Official product labeling indicates that the medicine has been associated with the development of or worsening of hypertension (high blood pressure). Official labeling advises that blood pressure monitoring is typically performed when initiating and continuing treatment.

Q: What kind of monitoring (like blood tests) is sometimes needed while on Voltic?

Official guidance indicates that monitoring is typically required, particularly during long-term therapy. This can include checking renal function (kidney health), hepatic function (liver enzymes), and blood cell counts (hematocrit/hemoglobin) at the start of treatment and periodically thereafter.

Q: Is Voltic designed to cure a condition or just manage symptoms?

Voltic is designed to manage the symptoms of pain, inflammation, swelling, and stiffness associated with various conditions. Official patient information clarifies that it is not intended to cure the underlying disease.

Q: How long does it typically take for a person to notice the effects of Voltic?

Noticeable effects for chronic conditions may begin within one week of starting treatment. However, official patient counseling information indicates that noticeable results can take several weeks to manifest.

Q: Does Voltic cause long-term weight changes or increase appetite?

Official adverse reaction reports indicate that weight changes have been reported in clinical experience. Any unexpected or significant changes in body weight are generally reported to a healthcare provider.

Q: Is Voltic known to cause significant fatigue or drowsiness?

Yes, regulatory adverse reaction reports indicate that side effects such as drowsiness, fatigue, and unusual tiredness have been reported. These effects may be relevant when assessing alertness and capacity to perform complex tasks.

Q: Is Voltic considered addictive or habit-forming?

The active ingredient in Voltic, Diclofenac, is categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is not classified as a controlled substance by the DEA or other major regulatory bodies.

Q: Can Voltic be used in children, and if so, what are the age limits?

Official regulatory labels for the oral formulations state that the safety and effectiveness of the drug have not been established in pediatric patients. This means its use and appropriate age limits have not been formally approved or defined in this population.

Q: How long does Voltic stay in your system after you stop taking it?

According to the official pharmacokinetics data, the medicine has a relatively short terminal plasma half-life of approximately 1 to 2 hours after oral dosing. A half-life is the time it takes for the concentration of the drug in the body to be reduced by half.

Q: Does Voltic have any known effects on fertility in men or women?

As with other NSAIDs, regulatory information indicates that use may temporarily delay or prevent ovulation in women. Regulatory guidance indicates that cessation of the medicine is a consideration for women who are having difficulty conceiving.

Q: Can Voltic cause strange dreams or sleep disturbances?

Yes, official adverse reaction reports list dream abnormalities and insomnia (difficulty sleeping) as potential side effects. These are classified under effects on the nervous system.

Q: Can Voltic be taken while fasting or does it require food?

Tablets and capsules generally do not have specific food restrictions. However, the powder/liquid formulation is typically directed to be taken on an empty stomach because food may interfere with its absorption.

Q: What is the physical appearance (color, shape) of the Voltic tablet/capsule?

The medicine is supplied in various dosage forms, including oral tablets and capsules, across multiple strengths. The specific color, shape, and markings are generally described in the How Supplied section of the packaging insert for the particular manufacturer and strength being used.

Q: Does taking Voltic affect your body's immune response?

Official regulatory warnings note that the medicine can cause rare but serious systemic adverse reactions. These reactions include DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) and potential changes in blood cell counts (hematologic toxicity).

Q: Can Voltic cause changes in mood or emotional state?

Yes, official adverse reaction reports classify changes in emotional state, including anxiety and depression, as potential side effects.

Q: Does Voltic affect sleep quality?

Adverse reaction reports indicate that changes in sleep quality, such as insomnia (difficulty falling or staying asleep) and dream abnormalities, have been reported as side effects.

How should Voltic be stored and disposed of?

How to Store and Dispose of Voltic (Diclofenac)

Voltic must be stored strictly according to regulatory mandates to ensure its stability. Keep the medicine at controlled room temperature, typically between 68°F to 77°F (20°C to 25°C), and protect it from freezing, excessive heat, moisture, and direct light. The product must remain in its tightly closed original container.

Official Requirements

Domain Constraint
Temperature Store below 77°F (25°C) or 86°F (30°C); keep from freezing.
Protection Guard against light and moisture.
Child Safety Keep out of the sight and reach of children.
Disposal Do not discard in wastewater or household trash; use a medication take-back program or follow official regulatory household disposal steps.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Voltic found in:

A-Z Index: